Company
Headquarters: Guildford, United Kingdom
Employees: 13
CEO: Mr. James Henry Barder
£96.8 Million
GBP as of Jan. 1, 2025
US$121.5 Million
Company | Market Cap (USD) |
---|---|
Novo Nordisk | $622.07 B |
Vertex Pharmaceuticals Incorporated | $113.24 B |
CSL Limited | $95.75 B |
Regeneron Pharmaceuticals, Inc. | $76.33 B |
Marinomed Biotech AG | $56.13 B |
Company | Market Cap (USD) |
---|---|
Lilly | $689.42 B |
Novo Nordisk | $622.07 B |
UnitedHealth Group | $487.54 B |
Johnson & Johnson | $353.05 B |
AbbVie | $301.60 B |
Futura Medical plc, a pharmaceutical company, researches and develops pharmaceutical drugs and medical devices for the consumer healthcare markets focusing on sexual health and pain relief management. The company offers CSD500, a condom that contains erectogenic gel. It is also developing MED3000, a topical gel for the treatment of erectile dysfunction that has completed Phase III clinical trials. In addition, the company develops pain relief products, including TPR100, a topical diclofenac pain relief gel; CBD100, a topical cannabidiol formulation; and TIB200, a topical ibuprofen pain relief gel. The company was incorporated in 2001 and is headquartered in Guildford, the United Kingdom.
Top 1-year algo backtest: +327.04%
$10,000 in March 2024 would now be $42,704 by following this algorithm daily at market close.
Use AI to boost your investing & swing trading, now!
Try Disfold DeepFinance FREE
Last Financial Reports Date | Dec. 31, 2023 |
Revenue TTM | £3.1 M |
EBITDA | £-6,833,498 |
Gross Profit TTM | £1.8 M |
Profit Margin | -210.03% |
Operating Margin | -358.11% |
Quarterly Revenue Growth | % |
Futura Medical plc has the following listings and related stock indices.
Stock: LSE: FUM wb_incandescent
Stock: FSX: GYX wb_incandescent
Stock: OTC: FAMDF wb_incandescent